MACK Annual Current Assets
$19.18 M
-$644.00 K-3.25%
31 December 2023
Summary:
As of February 5, 2025, MACK annual total current assets is $19.18 million, with the most recent change of -$644.00 thousand (-3.25%) on December 31, 2023. During the last 3 years, it has risen by +$2.64 million (+15.96%).MACK Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MACK Quarterly Current Assets
$244.32 M
+$225.13 M+1173.56%
01 March 2024
Summary:
As of February 5, 2025, MACK quarterly total current assets is $244.32 million, with the most recent change of +$225.13 million (+1173.56%) on March 1, 2024. Over the past year, it has increased by +$225.03 million (+1166.30%).MACK Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MACK Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.3% | +1166.3% |
| 3 y3 years | +16.0% | +1166.3% |
| 5 y5 years | -74.8% | +1166.3% |
MACK Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -90.5% | at high |
Merrimack Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $244.32 M(+1173.6%) |
| Dec 2023 | $4000.00(-50.0%) | $19.18 M(-0.6%) |
| Sept 2023 | - | $19.29 M(-0.8%) |
| June 2023 | - | $19.44 M(-0.9%) |
| Mar 2023 | - | $19.63 M(-1.0%) |
| Dec 2022 | $8000.00(-87.9%) | $19.83 M(+45.5%) |
| Sept 2022 | - | $13.63 M(-3.0%) |
| June 2022 | - | $14.04 M(-3.9%) |
| Mar 2022 | - | $14.61 M(-0.5%) |
| Dec 2021 | $66.00 K(-71.6%) | $14.68 M(-3.4%) |
| Sept 2021 | - | $15.19 M(-3.3%) |
| June 2021 | - | $15.71 M(-3.3%) |
| Mar 2021 | - | $16.25 M(-1.8%) |
| Dec 2020 | $232.00 K(-83.3%) | $16.54 M(-11.5%) |
| Sept 2020 | - | $18.68 M(-3.5%) |
| June 2020 | - | $19.37 M(-3.0%) |
| Mar 2020 | - | $19.97 M(+6.8%) |
| Dec 2019 | $1.39 M(-88.8%) | $18.69 M(-16.5%) |
| Sept 2019 | - | $22.40 M(-47.4%) |
| June 2019 | - | $42.56 M(-33.2%) |
| Mar 2019 | - | $63.69 M(-16.3%) |
| Dec 2018 | $12.44 M(-44.2%) | $76.10 M(-12.8%) |
| Sept 2018 | - | $87.27 M(+41.4%) |
| June 2018 | - | $61.73 M(-19.9%) |
| Mar 2018 | - | $77.11 M(-18.9%) |
| Dec 2017 | $22.28 M | $95.05 M(-17.8%) |
| Sept 2017 | - | $115.58 M(-18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $141.56 M(+205.9%) |
| Mar 2017 | - | $46.27 M(-19.4%) |
| Dec 2016 | $24.05 M(-28.2%) | $57.44 M(-35.9%) |
| Sept 2016 | - | $89.62 M(-24.7%) |
| June 2016 | - | $119.03 M(-25.9%) |
| Mar 2016 | - | $160.68 M(-20.2%) |
| Dec 2015 | $33.49 M(+26.6%) | $201.39 M(+184.0%) |
| Sept 2015 | - | $70.92 M(-5.3%) |
| June 2015 | - | $74.88 M(-24.6%) |
| Mar 2015 | - | $99.30 M(-24.8%) |
| Dec 2014 | $26.44 M(+2.6%) | $132.06 M(-18.6%) |
| Sept 2014 | - | $162.14 M(+56.1%) |
| June 2014 | - | $103.85 M(-25.2%) |
| Mar 2014 | - | $138.88 M(-16.7%) |
| Dec 2013 | $25.77 M(+24.7%) | $166.64 M(-16.8%) |
| Sept 2013 | - | $200.28 M(+133.0%) |
| June 2013 | - | $85.95 M(-19.5%) |
| Mar 2013 | - | $106.75 M(-16.8%) |
| Dec 2012 | $20.67 M(+4.9%) | $128.30 M(+23.3%) |
| Sept 2012 | - | $104.08 M(-13.5%) |
| June 2012 | - | $120.32 M(+162.8%) |
| Mar 2012 | - | $45.79 M(-30.2%) |
| Dec 2011 | $19.71 M(-7.4%) | $65.59 M(-5.7%) |
| Sept 2011 | - | $69.53 M(-16.7%) |
| June 2011 | - | $83.42 M(+88.0%) |
| Mar 2011 | - | $44.37 M(+22.3%) |
| Dec 2010 | $21.29 M(+3.1%) | $36.29 M |
| Dec 2009 | $20.64 M | - |
FAQ
- What is Merrimack Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual current assets year-on-year change?
- What is Merrimack Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly current assets year-on-year change?
What is Merrimack Pharmaceuticals annual total current assets?
The current annual current assets of MACK is $19.18 M
What is the all time high annual current assets for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual total current assets is $201.39 M
What is Merrimack Pharmaceuticals annual current assets year-on-year change?
Over the past year, MACK annual total current assets has changed by -$644.00 K (-3.25%)
What is Merrimack Pharmaceuticals quarterly total current assets?
The current quarterly current assets of MACK is $244.32 M
What is the all time high quarterly current assets for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly total current assets is $244.32 M
What is Merrimack Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, MACK quarterly total current assets has changed by +$225.03 M (+1166.30%)